New approaches to the treatment of thrombocytosis.
Fruchtman
Steven
S
Department of Hematology, Mount Sinai School of Medicine, USA.
D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D009196:Myeloproliferative Disorders / Q000188:drug therapy; D010976:Platelet Count; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use; D013922:Thrombocytosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
D016898:Interferon-alpha; D011799:Quinazolines; C021139:anagrelide; D006918:Hydroxyurea